INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo ALLERWAY (capsules)
SCHEDULING STATUS:
S0

PROPRIETARY NAME
(and dosage form):

ALLERWAY (capsules)

COMPOSITION
Each capsule contains:
330 mg of a standardized proprietary herbal blend (NR-A2) containing extracts from:
Tarminalia chebula
Terminalia bellerica
Emblica officinalis
Piper longum
Piper nigrum
Zingiber officinale
Albizia lebbeck

PHARMACOLOGICAL CLASSIFICATION
A 32.2 Other: Polyherbal medicine

PHARMACOLOGICAL ACTION
In vitro, in vivo and human clinical studies have shown that the standardized polyherbal extract (NR-A2) in ALLERWAY stabilizes mast cells, inhibits trypsin activity, inhibits hyaluronidase activity, promotes anti-5-hydroxytryptamine activity, exhibits anti-allergic and anti-inflammatory effect and promotes antioxidant activity.

INDICATIONS
ALLERWAY is indicated for the alleviation and relief of the symptoms of allergic rhinitis such as nasal congestion, sneezing and rhinorrhoea (runny nose).

CONTRA-INDICATIONS
None known

INTERACTIONS
None known

PREGNANCY AND LACTATION
Safety during pregnancy and lactation has not been established.

DOSAGE AND DIRECTIONS FOR USE
2 capsules twice daily after meals for 6 –12 weeks, then 1 capsule twice daily, thereafter.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS
Gastro-intestinal:
Less frequent: Hyperacidity, epigastric discomfort, and retrosternal discomfort
Rare: Vomiting, nausea, abdominal pain, loose stools, constipation, anorexia
Neurological:
Rare: Headache
Autonomic nervous system:
Rare:Dry mouth
Genitourinary:
Rare: Increased micturition
Skin:
Rare: Skin rash
Respiratory:
Rare: Chest congestion

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT
There are no known symptoms of overdosage. Treatment is symptomatic and supportive.

IDENTIFICATION
Blue and white capsules containing a light brown powder.

PRESENTATION
60 capsules packed in an HDPE bottle with a screw cap.

STORAGE INSTRUCTIONS
Store below 25°C in a dry place.
KEEP OUT OF REACH OF CHILDREN

REFERENCE NUMBER
To be allocated

NAME AND BUSINESS ADDRESS OF THE HOLDER OF THE CERTIFICATE OF REGISTRATION
Dr. Reddy's Laboratories (Pty) Ltd
3rd Floor TA Bank Building
160 Jan Smuts Avenue Rosebank
2196

DATE OF PUBLICATION OF THIS PACKAGE INSERT
July 2006

New addition to this site: November 2006
Source: Pharmaceutical Industry

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2008